
浏览全部资源
扫码关注微信
1.金华市中心医院消化内科,浙江 金华 321000
2.金华市中心医院病理科,浙江 金华 321000
丁进,E-mail:wdtih74@163.com
纸质出版日期:2023-04-25,
收稿日期:2022-09-08,
扫 描 看 全 文
杨小云,陈燕萍,胡益冰等.血清PDCD4、ZEB1、G-17联合检测对早期胃癌的诊断价值[J].局解手术学杂志,2023,32(04):323-326.
YANG Xiao-yun,CHEN Yan-ping,HU Yi-bing,et al.Diagnostic value of combined detection of serum PDCD4, ZEB1 and G-17 in early gastric cancer[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(04):323-326.
杨小云,陈燕萍,胡益冰等.血清PDCD4、ZEB1、G-17联合检测对早期胃癌的诊断价值[J].局解手术学杂志,2023,32(04):323-326. DOI: 10.11659/jjssx.09E022045.
YANG Xiao-yun,CHEN Yan-ping,HU Yi-bing,et al.Diagnostic value of combined detection of serum PDCD4, ZEB1 and G-17 in early gastric cancer[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(04):323-326. DOI: 10.11659/jjssx.09E022045.
目的
2
探究血清程序性细胞死亡因子4(PDCD4)、E盒结合锌指蛋白1(ZEB1)、胃泌素-17(G-17)联合检测对早期胃癌(GC)的诊断价值。
方法
2
将本院收治的136例GC患者、82例萎缩性胃炎患者分别设为GC组、萎缩性胃炎组,另选取同期136例体检健康者设为对照组。比较各组血清PDCD4 mRNA、ZEB1 mRNA及G-17、糖类抗原19-9(CA19-9)、癌胚抗原(CEA)水平。根据GC患者病情进展程度将其分为早期GC组(80例)和进展期GC组(56例),比较早期GC组、进展期GC组患者血清PDCD4 mRNA、ZEB1 mRNA及G-17、CA19-9、CEA水平;分析血清PDCD4 mRNA、ZEB1 mRNA、G-17、CA19-9、CEA单独或联合检测对早期GC的诊断价值。
结果
2
与对照组相比,萎缩性胃炎组、GC组患者血清PDCD4 mRNA表达水平降低(
P
<
0.05),ZEB1 mRNA、G-17水平升高(
P
<
0.05);与萎缩性胃炎组相比,GC组患者血清PDCD4 mRNA表达水平降低(
P
<
0.05),ZEB1 mRNA、G-17、CA19-9、CEA水平升高(
P
<
0.05)。进展期GC组患者血清PDCD4 mRNA表达水平低于早期GC组(
P
<
0.05),ZEB1 mRNA、G-17、CA19-9、CEA水平高于早期GC组(
P
<
0.05)。血清PDCD4、ZEB1、G-17联合诊断早期GC的曲线下面积(
AUC
)为0.946,高于三者单独诊断及CA19-9、CEA(
P
<
0.05),联合诊断的灵敏度为86.25%,特异度为94.64%,诊断价值最高。
结论
2
GC患者血清PDCD4 mRNA表达水平较低,ZEB1 mRNA、G-17水平较高,血清PDCD4、ZEB1、G-17均可辅助诊断早期GC,且三者联合检测可能更有益于临床筛查早期GC。
Objective
2
To explore the diagnostic value of combined detection of serum programmed cell death 4 (PDCD4), zinc finger E-box-binding homeobox 1 (ZEB1) and gastrin-17 (G-17) in early gastric cancer (GC).
Methods
2
A total of 136 patients with GC and 82 patients with atrophic gastritis admitted to our hospital were set as the GC group and the atrophic gastritis group, respectively; and 136 healthy people with physical examination in the same period were taken as the control group. The levels of serum PDCD4 mRNA, ZEB1 mRNA, G-17, carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) in each group were compared. According to the degree of progression of GC patients, they were divided into the early GC group (80 cases) and the advanced GC group (56 cases). The levels of serum PDCD4 mRNA, ZEB1 mRNA, G-17, CA19-9 and CEA of patients were compared between the early GC group and the advanced GC group. The diagnostic value of serum PDCD4 mRNA, ZEB1 mRNA, G-17, CA19-9 and CEA alone or in combination for early GC was analyzed.
Results
2
Compared with the control group, the expression level of serum PDCD4 mRNA in the atrophic gastritis group and the GC group decreased (
P
<
0.05), and the levels of ZEB1 mRNA and G-17 increased (
P
<
0.05). Compared with the atrophic gastritis group, the expression level of serum PDCD4 mRNA in the GC group decreased (
P
<
0.05), and the levels of ZEB1 mRNA, G-17, CA19-9 and CEA increased (
P
<
0.05). The expression level of serum PDCD4 mRNA in the advanced GC group was lower than that in the early GC group (
P
<
0.05), and the levels of ZEB1 mRNA, G-17, CA19-9 and CEA were higher than those in the early GC group (
P
<
0.05). The
area under the curve
(
AUC
) of serum PDCD4, ZEB1 and G-17 in the combined diagnosis of early GC was 0.946, which was higher than that of the three alone diagnosis or CA19-9 or CEA (
P
<
0.05), the sensitivity and specificity of the combined diagnosis were 86.25% and 94.64%, respectively, with the highest diagnostic value.
Conclusion
2
The expression level of serum PDCD4 mRNA in GC patients is lower, while the levels of ZEB1 mRNA and G-17 are higher. Serum PDCD4, ZEB1 and G-17 can assist in the diagnosis of early GC, and the combined detection of the three may be more beneficial for clinical screening of early GC.
程序性细胞死亡因子4胃泌素-17E盒结合锌指蛋白1早期胃癌诊断
programmed cell death 4gastrin-17zinc finger E-box-binding homeobox 1early gastric cancerdiagnosis
Zhang ZG,Xu L,Zhang PJ,et al.Evaluation of the value of multiparameter combined analysis of serum markers in the early diagnosis of gastric cancer[J].World J Gastrointest Oncol,2020,12(4):483-491.doi:10.4251/wjgo.v12.i4.483http://dx.doi.org/10.4251/wjgo.v12.i4.483.
Zhong H,Luo X.Serum dihydropyrimidinase-like 3 concentration in patients with gastric cancer and its diagnostic value[J].Iran J Public Health,2021,50(9):1789-1795.doi:10.18502/ijph.v50i9.7051http://dx.doi.org/10.18502/ijph.v50i9.7051.
刘健.血清miR-760表达对早期胃癌的诊断价值[J].山东医药,2021,61(16):77-79.doi:10.3969/j.issn.1002-266X.2021.16.018http://dx.doi.org/10.3969/j.issn.1002-266X.2021.16.018.
刘旭初,谭世运,梁彬,等.血清CEA,CA72-4,CA19-9及胃蛋白酶原水平对胃癌早期诊断的临床价值[J].中国现代普通外科进展,2022,25(3):196-200.doi:10.3969/j.issn.1009-9905.2022. 03.006http://dx.doi.org/10.3969/j.issn.1009-9905.2022.03.006.
饶向东,刘振宇,汤红亮,等.胃癌患者血清miR-181b和PDCD4水平表达与幽门螺杆菌感染的关系[J].现代检验医学杂志,2021,
36(4):1-4.doi:10.3969/j.issn.1671-7414.2021.04.001http://dx.doi.org/10.3969/j.issn.1671-7414.2021.04.001.
Gao ZY,Liu H,Zhang Z.miR-144-3p increases radiosensibility of
gastric cancer cells by targeting inhibition of ZEB1[J].Clin Transl
Oncol,2021,23(3):491-500.doi:10.1007/s12094-020-02436-1http://dx.doi.org/10.1007/s12094-020-02436-1.
詹长欣,詹雪梅,俞桦.血清G-17,PGⅠ,PGⅡ联合HP阳性检测用于胃癌筛查的价值[J].现代消化及介入诊疗,2021,26(6):772-774.doi:10.3969/j.issn.1672-2159.2021.06.026http://dx.doi.org/10.3969/j.issn.1672-2159.2021.06.026.
徐泽宽.2015年V1版《NCCN胃癌临床实践指南》更新解读[J].中国实用外科杂志,2015,35(5):512-514.doi:10.7504/CJPS.ISSN1005-2208.2015.05.16http://dx.doi.org/10.7504/CJPS.ISSN1005-2208.2015.05.16.
Wu P,Wang J,Mao X,et al.PDCD4 regulates apoptosis in human
peritoneal mesothelial cells and promotes gastric cancer peritoneal
metastasis[J].Histol Histopathol,2021,36(4):447-457.doi:10http://dx.doi.org/10.
14670/HH-18-305.
Kim JY,Lee H,Kim EK,et al.Low PDCD4 expression is associated with poor prognosis of colorectal carcinoma[J].Appl Immunohistochem Mol Morphol,2021,29(9):685-692.doi:10.1097/PAI. 0000000000000948http://dx.doi.org/10.1097/PAI.0000000000000948.
Yang YL,Liu P,Li D,et al.Stat-3 signaling promotes cell proliferation and metastasis of gastric cancer through PDCD4 downregulation[J].Kaohsiung J Med Sci,2020,36(4):244-249.doi:10.1002/kjm2.12159http://dx.doi.org/10.1002/kjm2.12159.
巴赫,彭强,朱耀东.胃癌组织中PDCD4基因的表达和甲基化水平及其临床意义[J].肿瘤防治研究,2020,47(12):942-946.doi:10.3971/j.issn.1000-8578.2020.20.0178http://dx.doi.org/10.3971/j.issn.1000-8578.2020.20.0178.
Dong Y,Li F,Wang J,et al.miR-369 inhibits liver cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients[J].J Cancer,2021,12(10):3067-3076.doi:10.7150/jca.54759http://dx.doi.org/10.7150/jca.54759.
Li D,Wang J,Zhang M,et al.LncRNA MAGI2-AS3 is regulated by BRD4 and promotes gastric cancer progression via maintaining ZEB1 overexpression by sponging miR-141/200a[J].Mol Ther Nucleic Acids,2020,19(3):109-123.doi:10.1016/j.omtn.2019.11.003http://dx.doi.org/10.1016/j.omtn.2019.11.003.
苏智祥,于滨,李旭,等.miR-101靶向调节ZEB1对胃癌细胞上皮间质转化及化疗敏感性的影响[J].中华内分泌外科杂志,2020,14(6):455-460.doi:10.3760/cma.j.cn.115807-20200630-00203http://dx.doi.org/10.3760/cma.j.cn.115807-20200630-00203.
刘伟,安杰,李康,等.胃癌组织/细胞中miR-429和ZEB1/2表达的相关性及临床意义[J].中国现代普通外科进展,2019,
22(5):369-373.doi:10.3969/j.issn.1009-9905.2019.05.008http://dx.doi.org/10.3969/j.issn.1009-9905.2019.05.008.
Wang Y,Zhu Z,Liu Z,et al.Diagnostic value of serum pepsinogen I,pepsinogen Ⅱ,and gastrin-17 levels for population-based screening for early-stage gastric cancer[J].J Int Med Res,2020,48(3):4826-4833.doi:10.1177/0300060520914826http://dx.doi.org/10.1177/0300060520914826.
Lin Z,Bian H,Chen C,et al.Application of serum pepsinogen and
carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17)
detection in the screening,diagnosis,and evaluation of early gastric cancer[J].J Gastrointest Oncol,2021,12(3):1042-1048.doi:10.21037/jgo-21-254http://dx.doi.org/10.21037/jgo-21-254.
袁培杰.血清PGⅠ,PGⅡ,PGR,G-17水平与Hp-IgG联合检测对胃癌早期诊断的临床价值分析[J].国际肿瘤学杂志,2020,
47(1):24-28.doi:10.3760/cma.j.issn.1673-422X.2020.01.004http://dx.doi.org/10.3760/cma.j.issn.1673-422X.2020.01.004.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621